HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hitoshi Hori Selected Research

Cytochalasin B

3/2006Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
2/2006Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
8/2005Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
9/2004Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
1/2003Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
1/2003Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hitoshi Hori Research Topics

Disease

37Neoplasms (Cancer)
08/2022 - 03/2002
9Hypoxia (Hypoxemia)
08/2012 - 05/2002
5Neoplasm Metastasis (Metastasis)
09/2010 - 09/2005
4Inflammation (Inflammations)
06/2008 - 11/2002
4Hyperthermia
02/2007 - 01/2003
3Pancreatic Neoplasms (Pancreatic Cancer)
08/2012 - 03/2004
2Breast Neoplasms (Breast Cancer)
08/2014 - 07/2013
2Cardiovascular Diseases (Cardiovascular Disease)
05/2014 - 01/2013
2Prostatic Neoplasms (Prostate Cancer)
07/2013 - 03/2009
2Lung Neoplasms (Lung Cancer)
07/2013 - 11/2005
2Ascites
07/2013 - 05/2002
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2005 - 09/2005
2Carcinoma (Carcinomatosis)
11/2005 - 05/2002
1Prion Diseases (Transmissible Spongiform Encephalopathies)
08/2014
1Heart Diseases (Heart Disease)
08/2014
1Lewis Lung Carcinoma
07/2013
1Colorectal Neoplasms (Colorectal Cancer)
07/2013
1Hepatocellular Carcinoma (Hepatoma)
01/2012
1Colonic Neoplasms (Colon Cancer)
10/2009
1Rectal Neoplasms (Rectal Cancer)
10/2009
1Lymphatic Metastasis
10/2009
1AIDS-Related Complex (ARC)
03/2009
1Neurofibromatoses (Neurofibromatosis)
03/2009
1Peritonitis
06/2008
1Persistent Infection
11/2007
1Tuberculosis (Tuberculoses)
11/2007
1Chronic Obstructive Pulmonary Disease (COPD)
11/2006
1Necrosis
11/2006

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
08/2014 - 05/2002
9vitamin D-binding protein-macrophage activating factorIBA
08/2014 - 05/2002
8Cytotoxins (Cytolysins)IBA
08/2012 - 05/2002
7Bromodeoxyuridine (BrdU)IBA
01/2007 - 01/2003
6Tirapazamine (SR 4233)IBA
09/2010 - 01/2003
6Cytochalasin BIBA
03/2006 - 01/2003
5BoronIBA
08/2022 - 12/2006
52-nitroimidazole acetamideIBA
10/2009 - 05/2002
5SuspensionsIBA
03/2006 - 01/2003
43-amino-2-quinoxalinecarbonitrileIBA
12/2006 - 11/2003
3Vitamin D-Binding ProteinIBA
07/2013 - 09/2004
3TX 2100IBA
09/2010 - 02/2006
3Propolis (Bee Bread)IBA
05/2009 - 07/2007
3artepillin CIBA
03/2009 - 07/2007
22- hydroxyarylidene- 4- cyclopentene- 1,3- dioneIBA
07/2016 - 03/2004
2EtanidazoleIBA
08/2014 - 01/2011
2AntioxidantsIBA
05/2014 - 05/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 11/2003
2SugarsIBA
09/2010 - 11/2006
2Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
09/2010 - 09/2008
2N-acetylcochinol-O-phosphateIBA
01/2007 - 08/2005
2DNA (Deoxyribonucleic Acid)IBA
12/2006 - 06/2005
2LipopolysaccharidesIBA
11/2005 - 09/2004
2Cisplatin (Platino)FDA LinkGeneric
06/2005 - 01/2003
1Cyclin-Dependent Kinase 2IBA
07/2016
1src-Family KinasesIBA
07/2016
1SF 6847IBA
07/2016
1Growth InhibitorsIBA
07/2016
1tin(IV) chlorin e6IBA
08/2014
1protoporphyrin IXIBA
08/2014
1phytochlorinIBA
08/2014
1Advanced Glycation End ProductsIBA
08/2014
1AcidsIBA
08/2014
1Hormones (Hormone)IBA
08/2014
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
07/2013
1VitaminsIBA
07/2013
1Cholecalciferol (Vitamin D3)FDA Link
07/2013
1Sepharose (Agarose)IBA
07/2013
1Thioctic Acid (Lipoic Acid)IBA
07/2013
1MannosidasesIBA
07/2013
1Bovine Serum AlbuminIBA
01/2013
1oxidized low density lipoproteinIBA
01/2013
1SolutionsIBA
01/2013
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2013
1LipidsIBA
01/2013
12- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA
08/2012
1TX-2098IBA
08/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2012
1Antineoplastic Agents (Antineoplastics)IBA
09/2010
1mannosyl-oligosaccharide 1,3 - 1,6-alpha-mannosidaseIBA
03/2010
1EnzymesIBA
03/2010
1Plasminogen Activators (Plasminogen Activator)IBA
10/2009
1Matrix Metalloproteinases (MMPs)IBA
10/2009
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
10/2009
1Phosphotransferases (Kinase)IBA
03/2009
1caffeic acid phenethyl esterIBA
03/2009
1ProstaglandinsIBA
06/2008
1CarrageenanIBA
06/2008
1NF-kappa B (NF-kB)IBA
06/2008
1Cytostatic AgentsIBA
12/2006
1TX-1898IBA
12/2006
1Type II Tumor Necrosis Factor ReceptorsIBA
11/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2006
1Type I Tumor Necrosis Factor ReceptorsIBA
11/2006

Therapy/Procedure

14Therapeutics
08/2014 - 05/2002
5Boron Neutron Capture Therapy
01/2016 - 09/2004
4Immunotherapy
08/2014 - 11/2005
2Radiotherapy
01/2016 - 03/2006
2Drug Therapy (Chemotherapy)
05/2014 - 03/2010
2Microspheres (Microsphere)
11/2007 - 08/2006
1Aftercare (After-Treatment)
01/2012
1Intravenous Administration
01/2011